Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ: GDRX )

4.420 -0.050 (-1.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,063,947
Open 4.520
Bid (Size) 4.420 (1)
Ask (Size) 4.490 (10)
Prev. Close 4.470
Today's Range 4.395 - 4.585
52wk Range 4.090 - 9.260
Shares Outstanding 412,429,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks Under $10 Skating on Thin Ice
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending
From GoodRx
Via Business Wire

Performance

YTD
-3.07%
-3.07%
1 Month
-12.30%
-12.30%
3 Month
-3.70%
-3.70%
6 Month
-42.45%
-42.45%
1 Year
-32.72%
-32.72%

More News

Read More
The Analyst Verdict: GoodRx Holdings In The Eyes Of 4 Experts
Via Benzinga
GoodRx (GDRX) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For February 27, 2025
Via Benzinga
Assessing GoodRx Holdings: Insights From 4 Financial Analysts
Via Benzinga
GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales
Via Benzinga
GoodRx (NASDAQ:GDRX) Misses Q4 Revenue Estimates
Via StockStory
GoodRx Reports Fourth Quarter and Full Year 2024 Results
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Earnings: What To Look For From GDRX
Via StockStory
GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
From GoodRx
Via Business Wire
1 Healthcare Stock Primed for Growth and 2 to Avoid
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
1 Healthcare Stock Primed for Growth and 2 to Snub
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
From GoodRx
Via Business Wire
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
Scott Wagner Joins GoodRx Board of Directors
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires
From GoodRx
Via Business Wire
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications
From GoodRx
Via Business Wire
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
From GoodRx
Via Business Wire
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
From GoodRx Holdings, Inc.
Via Business Wire
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
Via Benzinga
How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals
Via Benzinga
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
From GoodRx
Via Business Wire
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.